The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCapital & Regional Regulatory News (CAL)

Share Price Information for Capital & Regional (CAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 50.00
Bid: 49.90
Ask: 50.00
Change: 0.05 (0.10%)
Spread: 0.10 (0.20%)
Open: 50.00
High: 50.00
Low: 49.90
Prev. Close: 49.95
CAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Applicable Exchange Rate Announcement

17 Dec 2019 09:30

RNS Number : 1371X
Growthpoint Properties Limited
17 December 2019
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM, ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

 

FOR IMMEDIATE RELEASE

 

17 December 2019

 

Announcement regarding Recommended Partial Offer and Subscription for Shares in Capital & Regional plc ("Capital & Regional") by Growthpoint Properties Limited ("Growthpoint")

 

Applicable Exchange Rate Announcement

 

As explained in the offer document setting out the full terms and conditions of the Partial Offer published on 7 November 2019 (the "Offer Document"), Qualifying Capital & Regional Shareholders on the South African Register who validly accept the Partial Offer in respect of their Capital & Regional Shares are entitled to receive the equivalent of the Offer Price in South African rand based on the Applicable Exchange Rate.

Growthpoint today announces that the Applicable Exchange Rate is ZAR 18.9922 for each GBP 1.00.

The aggregate cash proceeds based on the Applicable Exchange Rate to which any Capital & Regional Shareholder on the South African Register shall be entitled under the Partial Offer shall be rounded down to the nearest South African cent.

As announced on 9 December 2019, payment will be despatched on 20 December 2019 to Capital & Regional Shareholders on the South African Register who validly accepted the Partial Offer.

Defined terms used but not defined in this announcement have the meanings set out in the Offer Document.

Enquiries:

Growthpoint Lauren Turner, Investor Relations

+27 (0) 11 944 6346

Goldman Sachs (Financial adviser to Growthpoint)Nick HarperOlivier FrendoDimitri VlachosBenjamin Holt

+44 (0) 20 7774 1000

Java Capital Trustees and Sponsors (JSE sponsor to Capital & Regional)

 

+ 27 (0) 11 722 3050

Investec Bank Limited (JSE sponsor to Growthpoint)

+ 27 (0) 11 286 7000

 

Important Notices

 

Goldman Sachs International ("Goldman Sachs"), which is authorised by the Prudential Regulation Authority ("PRA") and regulated by the Financial Conduct Authority ("FCA") and the PRA in the United Kingdom, is acting as financial adviser to Growthpoint and no one else in connection with the matters described in this Announcement and will not be responsible to anyone other than Growthpoint for providing the protections afforded to clients of Goldman Sachs, or for giving advice in connection with the matters described in this Announcement or any matter referred to herein. Neither Goldman Sachs nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Goldman Sachs in connection with this Announcement or any matter referred to herein.

 

This announcement is for information purposes only and does not constitute an offer to sell or an invitation to purchase any securities or the solicitation of an offer to buy any securities, pursuant to the Partial Offer or otherwise. The Partial Offer is being made solely pursuant to the terms of the Offer Document which contains the full terms and conditions of the Partial Offer, and in the case of Capital & Regional shares held in certificated form on the UK Register, the Form of Acceptance. Any decision or acceptance in relation to the Partial Offer should be made only on the basis of the information contained in the Offer Document and Form of Acceptance (if applicable). Capital & Regional Shareholders are advised to read carefully the Offer Document and Form of Acceptance (if applicable), once they have been received.

 

This announcement has been prepared for the purpose of complying with English law and the City Code and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws of jurisdictions outside the United Kingdom.

 

Overseas Shareholders

 

The information contained herein is not for release, distribution or publication, directly or indirectly, in or into Australia, Canada, Japan, New Zealand, the United States, or any other jurisdiction where the relevant action would constitute a violation of the relevant laws and regulations of such jurisdiction or would result in a requirement to comply with any governmental or other consent or any registration, filing or other formality which Growthpoint regards as unduly onerous (each a "Restricted Jurisdiction"). The release, publication or distribution of this announcement in jurisdictions other than the United Kingdom may be restricted by law and therefore any persons who are subject to the laws of any jurisdiction other than the United Kingdom should inform themselves about, and observe any applicable requirements.

 

Unless otherwise determined by Growthpoint or required by the City Code, and permitted by applicable law and regulation, the Partial Offer is not being made, directly or indirectly, in, into or from, by use of the mails of, or by any other means or instrumentality (including, without limitation, electronic mail, facsimile transmission, telex, telephone, internet or other forms of electronic communication) of foreign or interstate commerce of, or any facilities of a national, state or other securities exchange of, any Restricted Jurisdiction, and shall not be capable of acceptance by any such use, means, instrumentality or facility or from or within any Restricted Jurisdiction. Accordingly, copies of the Offer Document, the Form of Acceptance and any related documents are not being (unless determined otherwise by Growthpoint in its sole discretion or required by the City Code, and permitted by applicable law and regulation), and must not be, directly or indirectly mailed, transmitted or otherwise forwarded, distributed, sent or otherwise made available (including, without limitation, by agents, custodians, nominees or trustees) in, into or from a Restricted Jurisdiction, and persons receiving the Offer Document and/or Form of Acceptance and/or any related documents (including, without limitation, agents, custodians, nominees and trustees) should observe these restrictions and must not mail or otherwise forward, distribute, send or otherwise make them available in, into or from such jurisdiction.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
OUPZMMMZLNFGLZG
Date   Source Headline
22nd Apr 20247:01 amRNSAppointment of Non-Executive Director
22nd Apr 20247:00 amRNSNotice of Results
2nd Apr 20247:00 amRNSDividend Finalisation Announcement
11th Mar 20249:30 amRNSBoard Notification
8th Mar 20247:00 amRNSUpdate on Year End results
8th Feb 20241:00 pmRNSHolding(s) in Company
5th Feb 202410:00 amRNSChange of Adviser
10th Oct 20237:00 amRNSDirector/PDMR Shareholding
4th Oct 20231:00 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSAcquisition of shares by Employee Share Trust
14th Sep 202311:15 amRNSHolding(s) in Company
13th Sep 20237:00 amRNSResults of Scrip Dividend Election
7th Sep 20233:00 pmRNSHolding(s) in Company
25th Aug 20237:00 amRNSResult of Open Offer
22nd Aug 202310:00 amRNSDividend Finalisation Announcement
10th Aug 20232:05 pmRNSPublication of Prospectus
10th Aug 20239:00 amRNSBoard Notification
10th Aug 20237:01 amRNSHalf Year Results to 30 June 2023
10th Aug 20237:00 amRNSAcquisition and Launch of Open Offer
24th Jul 20239:30 amRNSNOTICE OF HALF YEAR RESULTS – UPDATED TIMINGS
24th Jul 20237:00 amRNSNotice of Half Year Results
7th Jun 20237:00 amRNSDirector Shareholding
25th May 20232:02 pmRNSResults of Scrip dividend election
25th May 20232:01 pmRNSChange of Auditor
25th May 20232:00 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Trading Update
16th May 20232:45 pmRNSHolding(s) in Company
2nd May 20234:00 pmRNSCombined Incentive Plan award
28th Apr 20234:04 pmRNSNotice of AGM and publication of Annual Report
24th Apr 20234:15 pmRNSResults of Scrip Dividend Election
31st Mar 202310:00 amRNSDividend Finalisation Announcement
17th Mar 20237:00 amRNSDisposal of The Mall, Luton
2nd Mar 20237:00 amRNSFull Year Results to 30 December 2022
1st Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 202312:00 pmRNSBoard Notification
20th Feb 20237:00 amRNSAppointment of Director
14th Feb 20237:00 amRNSNotice of 2022 Full Year Results
30th Jan 20234:40 pmRNSSecond Price Monitoring Extn
30th Jan 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20234:40 pmRNSSecond Price Monitoring Extn
26th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
14th Dec 20224:35 pmRNSPrice Monitoring Extension
7th Dec 20222:00 pmRNSUpdate on Trading and Property Portfolio
16th Nov 202211:00 amRNSChange of Auditor
5th Oct 20224:00 pmRNSTotal Voting Rights
3rd Oct 20224:35 pmRNSPrice Monitoring Extension
26th Sep 20224:36 pmRNSPrice Monitoring Extension
26th Sep 20224:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.